Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients
Terminated
- Conditions
- Cell-mediated Immune Response
- Interventions
- Device: QuantiFERON Monitor AssayDevice: Existing methodology
- Registration Number
- NCT02416414
- Lead Sponsor
- QIAGEN Gaithersburg, Inc
- Brief Summary
To compare the performance of the QuantiFERON Monitor assay against existing methodology.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 166
Inclusion Criteria
- Provide Informed Consent
- Received a solid organ transplant
Exclusion Criteria
- Pregnancy or recent lactation (<1yr)
- Treatment of Rejection
Healthy Control
Inclusion Criteria:
- Provide Informed Consent
Exclusion Criteria:
- Currently taking any immunomodulatory medication
- A history of immunosuppressive disease or immunosuppression condition or history of autoimmune diseases
- Current pregnancy or recent lactation (<1yr)
- Currently taking antiviral medication
- Currently being treated for infectious diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Solid Organ Transplant Recipients Existing methodology Subjects who have received a Solid Organ Transplant. Healthy Controls QuantiFERON Monitor Assay Healthy individuals. Solid Organ Transplant Recipients QuantiFERON Monitor Assay Subjects who have received a Solid Organ Transplant. Healthy Controls Existing methodology Healthy individuals.
- Primary Outcome Measures
Name Time Method Cell-mediated immune response. 1 day (At time of enrollment)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
University of California Los Angeles
🇺🇸Los Angeles, California, United States
The Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States